Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
3 clinical trials · Sponsor
◉ Watch Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
| Record | Firm | Date |
|---|---|---|
| Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults (NCT04311957) | Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic | 2020-09-01 |
| Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD (NCT04311944) | Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic | 2020-09-01 |
| Same-Day Treatment With Genvoya vs. EFV/TDF/3TC (NCT03405194) | Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic | 2018-05-01 |
Track Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic automatically
Every clearance here is in the API, with alerts when new ones post.